Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca halts development of anti-obesity drug
AstraZeneca halts development of anti-obesity drug
AstraZeneca halts development of anti-obesity drug
Submitted by
admin
on September 10, 2012 - 11:23am
Source:
Marketwatch
News Tags:
obesity
Palatin
AstraZeneca
AZD2820
Headline:
AstraZeneca halts development of anti-obesity drug
Do Not Allow Advertisers to Use My Personal information
